Topics
October 2015 | Special Focus: Uveitis
Promising Pipeline for Treatment of Noninfectious Posterior Uveitis
Agents and delivery mechanisms in development may offer physicians assistance in treating this heterogeneous disorder.
Steven Yeh, MD
May 13, 2026
NeuroVision Acquires Durin Life Sciences to Expand Neurodegenerative Disease Diagnostics Platform
Study: Popular GLP-1 Drugs Linked to Certain Optic Nerve Disorders
May 12, 2026
Astellas Presents New Izervay Data Showing Reduced Risk of Losing Driving Eligibility in GA Patients
AMA Unveils New Policy Framework to Combat AI “Deepfake” Impersonation of Physicians
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
